Copyright Reports & Markets. All rights reserved.

Global Antidiabetics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Antidiabetics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Rapid Acting
      • 1.4.3 Long Acting
      • 1.4.4 Short Acting
      • 1.4.5 Other
    • 1.5 Market by Application
      • 1.5.1 Global Antidiabetics Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Antidiabetics Market Size
    • 2.2 Antidiabetics Growth Trends by Regions
      • 2.2.1 Antidiabetics Market Size by Regions (2014-2025)
      • 2.2.2 Antidiabetics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Antidiabetics Market Size by Manufacturers
      • 3.1.1 Global Antidiabetics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Antidiabetics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Antidiabetics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Antidiabetics Key Players Head office and Area Served
    • 3.3 Key Players Antidiabetics Product/Solution/Service
    • 3.4 Date of Enter into Antidiabetics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Antidiabetics Market Size by Type (2014-2019)
    • 4.2 Global Antidiabetics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Antidiabetics Market Size (2014-2019)
    • 5.2 Antidiabetics Key Players in United States
    • 5.3 United States Antidiabetics Market Size by Type
    • 5.4 United States Antidiabetics Market Size by Application

    6 Europe

    • 6.1 Europe Antidiabetics Market Size (2014-2019)
    • 6.2 Antidiabetics Key Players in Europe
    • 6.3 Europe Antidiabetics Market Size by Type
    • 6.4 Europe Antidiabetics Market Size by Application

    7 China

    • 7.1 China Antidiabetics Market Size (2014-2019)
    • 7.2 Antidiabetics Key Players in China
    • 7.3 China Antidiabetics Market Size by Type
    • 7.4 China Antidiabetics Market Size by Application

    8 Japan

    • 8.1 Japan Antidiabetics Market Size (2014-2019)
    • 8.2 Antidiabetics Key Players in Japan
    • 8.3 Japan Antidiabetics Market Size by Type
    • 8.4 Japan Antidiabetics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Antidiabetics Market Size (2014-2019)
    • 9.2 Antidiabetics Key Players in Southeast Asia
    • 9.3 Southeast Asia Antidiabetics Market Size by Type
    • 9.4 Southeast Asia Antidiabetics Market Size by Application

    10 India

    • 10.1 India Antidiabetics Market Size (2014-2019)
    • 10.2 Antidiabetics Key Players in India
    • 10.3 India Antidiabetics Market Size by Type
    • 10.4 India Antidiabetics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Antidiabetics Market Size (2014-2019)
    • 11.2 Antidiabetics Key Players in Central & South America
    • 11.3 Central & South America Antidiabetics Market Size by Type
    • 11.4 Central & South America Antidiabetics Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Antidiabetics Introduction
      • 12.1.4 Pfizer Revenue in Antidiabetics Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 AstraZeneca
      • 12.2.1 AstraZeneca Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Antidiabetics Introduction
      • 12.2.4 AstraZeneca Revenue in Antidiabetics Business (2014-2019)
      • 12.2.5 AstraZeneca Recent Development
    • 12.3 Johnson & Johnson
      • 12.3.1 Johnson & Johnson Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Antidiabetics Introduction
      • 12.3.4 Johnson & Johnson Revenue in Antidiabetics Business (2014-2019)
      • 12.3.5 Johnson & Johnson Recent Development
    • 12.4 GlaxoSmithKline
      • 12.4.1 GlaxoSmithKline Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Antidiabetics Introduction
      • 12.4.4 GlaxoSmithKline Revenue in Antidiabetics Business (2014-2019)
      • 12.4.5 GlaxoSmithKline Recent Development
    • 12.5 Merck & Co
      • 12.5.1 Merck & Co Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Antidiabetics Introduction
      • 12.5.4 Merck & Co Revenue in Antidiabetics Business (2014-2019)
      • 12.5.5 Merck & Co Recent Development
    • 12.6 Eli Lilly
      • 12.6.1 Eli Lilly Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Antidiabetics Introduction
      • 12.6.4 Eli Lilly Revenue in Antidiabetics Business (2014-2019)
      • 12.6.5 Eli Lilly Recent Development
    • 12.7 Sanofi
      • 12.7.1 Sanofi Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Antidiabetics Introduction
      • 12.7.4 Sanofi Revenue in Antidiabetics Business (2014-2019)
      • 12.7.5 Sanofi Recent Development
    • 12.8 Takeda Pharmaceuticals
      • 12.8.1 Takeda Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Antidiabetics Introduction
      • 12.8.4 Takeda Pharmaceuticals Revenue in Antidiabetics Business (2014-2019)
      • 12.8.5 Takeda Pharmaceuticals Recent Development
    • 12.9 Novo Nordisk
      • 12.9.1 Novo Nordisk Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Antidiabetics Introduction
      • 12.9.4 Novo Nordisk Revenue in Antidiabetics Business (2014-2019)
      • 12.9.5 Novo Nordisk Recent Development
    • 12.10 Servier Laboratories
      • 12.10.1 Servier Laboratories Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Antidiabetics Introduction
      • 12.10.4 Servier Laboratories Revenue in Antidiabetics Business (2014-2019)
      • 12.10.5 Servier Laboratories Recent Development
    • 12.11 Boehringer Ingelheim
    • 12.12 Bristol-Myers Squibb
    • 12.13 MannKind
    • 12.14 BIOTON
    • 12.15 Salix Pharmaceuticals

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Antidiabetics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Antidiabetics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Antidiabetics development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      AstraZeneca
      Johnson & Johnson
      GlaxoSmithKline
      Merck & Co
      Eli Lilly
      Sanofi
      Takeda Pharmaceuticals
      Novo Nordisk
      Servier Laboratories
      Boehringer Ingelheim
      Bristol-Myers Squibb
      MannKind
      BIOTON
      Salix Pharmaceuticals

      Market segment by Type, the product can be split into
      Rapid Acting
      Long Acting
      Short Acting
      Other

      Market segment by Application, split into
      Hospitals
      Clinics
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Antidiabetics status, future forecast, growth opportunity, key market and key players.
      To present the Antidiabetics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Antidiabetics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now